Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Papillomavirus Infections × Clear all

Phase

Phase 2 5 Phase NA 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Completed 13 Recruiting 7 Active not recruiting 5 Unknown 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 11 Neoplasm Metastasis 10 Prostatic Neoplasms 9 Colorectal Neoplasms 8 Polycystic Ovary Syndrome 7 Pain 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Leiomyoma 6 Anemia 5 Skin Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia 4 Carcinoma, Renal Cell 4 Recurrence 3 Melanoma 3 Liver Neoplasms 3 Keratosis, Actinic 3 Insulin Resistance 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Pneumonia 2

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 Engerix-B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡